Creative Biolabs Unveils LNP Conjugation Platforms to Advance Precision Gene Therapy
Creative Biolabs announced the launch of its enhanced lipid nanoparticle (LNP) conjugation platform—solving long‑standing challenges in nucleic acid delivery for gene therapy and RNA‑based therapeutics.














